AB SCIEX Expands in Singapore
News Nov 01, 2013
The facility is an extension of the company's $10-million global operations in Marsiling where life science industry-leading analytical instruments, including the AB SCIEX 6500 series and TripleTOF®series, are manufactured.
The AB SCIEX R&D Centre is focused on product development and brings R&D and manufacturing closer together. As a global leader in scientific technologies for biological and chemical analysis, AB SCIEX spends close to 10 percent of its annual revenues on R&D, which is a driving force for the company's continued innovation in LC/MS/MS (liquid chromatography/tandem mass spectrometry).
The company has also invested in an application support and training facility in the Biopolis, which is Singapore's state-of-the-art biomedical research hub housing a community of public and private researchers.
"Our significant investments in research and development, manufacturing and personnel reaffirm our commitment to Singapore as a hub for AB SCIEX global operations," said Rainer Blair, President of AB SCIEX. "As a trusted partner with scientists all over the world, we will continue to drive new innovation and push the limits of analytical science."
AB SCIEX joins more than 50 biotechnology and life science companies that have an R&D presence in Singapore.
"We are excited about the opening of AB SCIEX's R&D Centre in Singapore ‒ its first R&D centre outside North America. The centre will design and develop new instruments from Singapore for global markets. This is an excellent example of how leading life science tools companies such as AB SCIEX are looking to Singapore as an integrated home in Asia for complex instrument manufacturing, headquarter functions as well as R&D to support their future growth," said Ms Thien Kwee Eng, Assistant Managing Director, Singapore Economic Development Board.
The company's expansion in Singapore positions AB SCIEX to better serve its customers across Asia-Pacific.
"Our proximity to Asia-Pacific customers creates greater opportunities for regional input into new products that can transform health and safety," said KY Wong, Vice President of Global Operations at AB SCIEX. "Also, by being in Singapore, we have strategic access to the Asian market's supply chain resources."
On the production side, AB SCIEX has completed the transfer of manufacturing Eksigent chromatography products from the United States to Singapore. The physical expansion of manufacturing in its Marsiling factory in northern Singapore is part of a progressive plan for the Southeast Asian manufacturing operation to take on an increased number of products.
3,000-Year-Old Textiles Are Earliest Evidence of Chemical DyeingNews
Discovery provides insight into society and copper production in the Timna region at the time of David and Solomon.READ MORE
Steaming Fish Eliminates More Cyanotoxins Than BoilingNews
Utilizing UHPLC researchers have shown that steaming freshwater fish for more than two minutes reduces the presence of the cyanotoxin, cylindrospermopsin, by up to 26% compared to 18% for boiling.READ MORE
Tiny “Tornado” Boosts Performance of Electrospray Ionization Mass SpectrometryNews
Known as Dry Ion Localization and Locomotion (DRILL), the new device creates a swirling flow that can separate electrospray droplets depending on their size.READ MORE
Comments | 0 ADD COMMENT
18th International Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques
Nov 02 - Nov 03, 2017